Tranche Update on AptarGroup, Inc.'s Equity Buyback Plan announced on April 18, 2019.
February 08, 2024 at 05:05 pm EST
Share
From October 1, 2023 to December 31, 2023, the company has repurchased 81,069 shares, representing 0.12% for $10.25 million. With this, the company has completed the repurchase of 2,493,225 shares, representing 3.83% for $289.32 million under the buyback announced on April 18, 2019.
AptarGroup, Inc. is engaged in designing and manufacturing of drug and consumer product dosing, dispensing and protection technologies. The Company serves various end markets, including pharmaceutical, beauty, food, beverage, personal care and home care. The Company operates through three segments: Aptar Pharma, Aptar Beauty and Aptar Closures. Aptar Pharma segment supplies nasal drug delivery spray pumps and metered dose inhaler valves (MDIs) to the pharmaceutical and healthcare markets worldwide and supplies elastomer for injectable primary packaging components worldwide. The segment also provides services designed to accelerate and de-risk the development and regulatory approvals of drugs using drug delivery devices. The Aptar Beauty segment sells a variety of pumps, airless systems and valves to the fragrance, color cosmetics, facial skincare, personal care and home care markets. Aptar Closures segment primarily sells dispensing closures.
APTARGROUP, INC. 
